Cancer Treatment Reviews
Volume 31, Issue 6 , Pages 491-495, October 2005

Tamoxifen does not improve overall survival in people with advanced-stage hepatocellular carcinoma☆☆☆☆☆☆

Department of General Surgery, Singapore General Hospital, Singapore, Republic of Singapore

Abstracted from: Nowak AK, Stockler MR, Chow PKH, Findlay M. Use of tamoxifen in advanced-stage hepatocellular carcinoma: a systematic review. Cancer 2005;103:1408–14.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Sources of funding: Not stated.

☆☆ For correspondence: Martin R Stockler, MBBS, NHMRC Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW 1450, Australia. E-mail: stockler@med.usyd.edu.au.

☆☆☆ Abstract provided by Bazian Ltd., London.

PII: S0305-7372(05)00130-1

doi:10.1016/j.ctrv.2005.07.005

Cancer Treatment Reviews
Volume 31, Issue 6 , Pages 491-495, October 2005

Article Tools